Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study

被引:9
|
作者
Tan, Jeffrey H. J. [1 ,2 ]
Malloy, Michael J. [3 ,4 ]
Thangamani, Ramaish [1 ]
Gertig, Dorota [4 ]
Drennan, Kelly T. [3 ]
Wrede, C. David [1 ,2 ]
Saville, Marion [5 ]
Quinn, Michael [1 ,2 ]
机构
[1] Royal Womens Hosp, Dept Oncol & Dysplasia, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia
[3] Victorian Cerv Cytol Registry, Melbourne, Vic, Australia
[4] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[5] Victorian Cytol Serv Ltd, Melbourne, Vic, Australia
关键词
adenocarcinoma in situ; cone biopsy cervix; glandular neoplasia cervix; loop excision cervix; recurrence; UTERINE CERVIX;
D O I
10.1111/ajo.13047
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Adenocarcinoma in situ of cervix is increasingly managed by local excision rather than hysterectomy and this study will ascertain if conservative management by excision alone is adequate. Aims To evaluate the long-term outcomes of conservative management of adenocarcinoma in situ of cervix, particularly in relation to excisional margin status. Materials and Methods Retrospective analysis of women diagnosed with adenocarcinoma in situ and their management between 1992 and 2010 retrieved from the Victorian Cervical Cytology Registry, Australia. Failure of conservative treatment is defined by histologically proven adenocarcinoma in situ or adenocarcinoma at follow-up after negative excisional margins. Results adenocarcinoma in situ of the cervix was managed primarily with cold knife cone biopsy or loop electrosurgical excision of the cervix. Most excisions were in one piece (83.4%) with average depth of 16.1 mm and 21.9% had involved excisional margins. Women with adenocarcinoma in situ on any excisional margin were more likely to have residual or recurrent disease (28.7%) compared with negative excisional margins (4.3%). Residual adenocarcinoma in situ was twice as common if adenocarcinoma in situ was present at endocervical (29.6%) and stromal (23.1%) margins compared with an ectocervical margin (13.6%). Cancer incidence at follow-up was 2.3% for women with positive excisional margins compared to 1.3% with negative margins. Conclusions Women with adenocarcinoma in situ of cervix can be managed with local excisional procedures, best in single pieces to provide the important information on excisional margins. Adenocarcinoma in situ at endocervical and stromal excisional margins needs re-excision or where appropriate, hysterectomy, while negative excisional margins have a low rate of recurrence and can be followed up with test of cure.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [31] Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ
    Laura E. G. Warren
    Yu-Hui Chen
    Lia M. Halasz
    Jane E. Brock
    Alexander Capuco
    Rinaa S. Punglia
    Julia S. Wong
    Mehra Golshan
    Jennifer R. Bellon
    Breast Cancer Research and Treatment, 2019, 178 : 607 - 615
  • [32] Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ
    Warren, Laura E. G.
    Chen, Yu-Hui
    Halasz, Lia M.
    Brock, Jane E.
    Capuco, Alexander
    Punglia, Rinaa S.
    Wong, Julia S.
    Golshan, Mehra
    Bellon, Jennifer R.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 607 - 615
  • [33] Conservative Treatment for Cervical Adenocarcinoma In Situ: Long-Term Results
    Monti, Ermelinda
    Somigliana, Edgardo
    Alberico, Daniela
    Boero, Veronica
    Iorio, Maria
    Di Loreto, Eugenia
    Dell'acqua, Andrea
    Liverani, Carlo Antonio
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2022, 26 (04) : 293 - 297
  • [34] Long-term experience in the surgical management of cancer of the uterine cervix
    Chi, DS
    Gemignani, ML
    Curtin, JP
    Hoskins, WJ
    SEMINARS IN SURGICAL ONCOLOGY, 1999, 17 (03): : 161 - 167
  • [35] Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review
    Park, Andrew J.
    Paul, Joan
    Chapman, M. Shane
    Samie, Faramarz H.
    DERMATOLOGIC SURGERY, 2017, 43 (08) : 1017 - 1022
  • [36] Metastatic and recurrent adenocarcinoma of the uterine cervix: a long-term survival of 16 years
    Peregrin-Alvarez, I.
    Akl, M. N.
    Morrow, C. P.
    Magrina, J. F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (03) : 333 - 335
  • [37] Long-term response to Trastuzumab in patients with advanced gastric or gastroesophageal adenocarcinoma - A retrospective study
    Porth, Isabel
    Weidner, Philip
    Lorenzen, Sylvie
    Weichert, Wilko
    Goetze, Thorsten Oliver
    Perner, Sven
    Luley, Kim
    Hirsch, Daniela
    Hofheinz, Ralf -Dieter
    Peckys, Diana B.
    Mostajeran, Zahra
    de Jonge, Niels
    Gaiser, Timo
    CANCER RESEARCH, 2022, 82 (12)
  • [38] Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study
    Jensen, Kristian K.
    Storkholm, Jan H.
    Chen, Inna
    Burgdorf, Stefan K.
    Hansen, Carsten P.
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 100
  • [39] Long-Term Outcomes of Elagolix in Women With Endometriosis
    Surrey, Eric
    Taylor, Hugh S.
    Giudice, Linda
    Lessey, Bruce A.
    Abrao, Mauricio S.
    Archer, David F.
    Diamond, Michael P.
    Johnson, Neil P.
    Watts, Nelson B.
    Gallagher, J. Chris
    Simon, James A.
    Carr, Bruce R.
    Dmowski, W. Paul
    Leyland, Nicholas
    Singh, Sukhbir S.
    Rechberger, Tomasz
    Agarwal, Sanjay K.
    Duan, W. Rachel
    Schwefel, Brittany
    Thomas, James W.
    Peloso, Paul M.
    Ng, Juki
    Soliman, Ahmed M.
    Chwalisz, Kristof
    OBSTETRICS AND GYNECOLOGY, 2018, 132 (01): : 147 - 160
  • [40] Long-Term Outcomes of a RCT Intervention Study for Women with Violent Crimes
    Kubiak, Sheryl
    Fedock, Gina
    Kim, Woo Jong
    Bybee, Deborah
    JOURNAL OF THE SOCIETY FOR SOCIAL WORK AND RESEARCH, 2016, 7 (04) : 661 - 679